1311964-64-3

Upstream product

• 5632-81-5 3,5-diamino-2-chloropyridine 
• 2578-45-2 2-chloro-3,5-dinitropyridine 
• 1178587-03-5 C₃₂H₅₄N₄O₈Si 
• 1311966-25-2 C₂₄H₄₈N₄O₆Si 
• 1178587-30-8 C₃₂H₅₄N₄O₈Si 
• 849160-51-6 di-tert-butyl ((3S,5R)-1-(4-methoxybenzyl)piperidine-3,5-diyl)dicarbamate 

Downstream Products

• 1178587-09-1 C₁₆H₂₄N₄O₄ 

Relevant academic research and scientific papers

A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site

(Figure Presented) DAPper ligands: The 3,5-diaminopiperidine (DAP) heterocycle has been developed as a structural mimetic of the RNA-recognizing pharmacophore of the 2-DOS scaffold. Here we describe the synthesis of novel modular DAP ligands that bind to a conformational target in the internal ribosome entry site RNA of the hepatitis C virus.

ANTIVIRAL COMPOUNDS FOR THE TREATMENT OF HCV INFECTION

Disclosed are compounds and methods of synthesis of Formula I for the development of antiviral drugs for the treatment of HCV infection.